Apollo Hospitals Enterprise Limited has scheduled a meeting of its equity shareholders on June 24, 2026, to seek approval for a composite scheme of arrangement. The meeting, convened pursuant to orders from the National Company Law Tribunal (NCLT), Chennai Bench, will be held through video conferencing and other audio-visual means at 2:30 PM IST.

The primary agenda is the approval of a scheme involving the demerger of an identified business undertaking into Apollo Healthtech Limited (Resultant Company) and the amalgamation of Apollo Healthco Limited (Transferor Company 1) and Keimed Private Limited (Transferor Company 2) with the Resultant Company. The scheme aims to streamline operations by carving out distinct business verticals into focused entities.

Meeting and Voting Details

Shareholders whose names appear in the register of members or beneficial owners as on the cut-off date of June 17, 2026, are entitled to attend and vote. The company has appointed National Securities Depository Limited (NSDL) to facilitate the voting process and the virtual meeting.

Scheme Structure and Approvals

The composite scheme provides for the issuance of fully paid-up equity shares of the Resultant Company to eligible shareholders of the Demerged Company and the transferor companies based on specific entitlement ratios. The scheme has received necessary no-objection letters from BSE Limited and the National Stock Exchange of India Limited (NSE) and approval from the Competition Commission of India (CCI).

Pursuant to the scheme, the Resultant Company will be listed on the stock exchanges. The authorized and paid-up share capital of the involved entities will undergo changes to accommodate the issuance of shares and the cancellation of capital in the transferor companies upon the scheme's effectiveness.

Apollo Hospitals Enterprise Ltd. recorded a notable block trade on the National Stock Exchange (NSE), with the transaction valued at ₹25.48 crores. The deal involved approximately 30,304 shares changing hands at a price of ₹8406.50 per share.

Block Trade Details

The following table summarizes the key parameters of the block trade executed on the NSE:

Block trades are large, privately negotiated transactions that are executed outside the open market to minimize the impact on the prevailing market price. Such trades are typically carried out by institutional investors and are reported separately on the exchange platform. The execution of a block trade of this size in Apollo Hospitals Enterprise Ltd. reflects significant transactional activity in the stock at the stated price level.